Allergan Plc
(NYSE : AGN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan Plc -1.26%188.202.9%$433.81m
ZTSZoetis, Inc. -1.46%136.321.9%$228.08m
TEVATeva Pharmaceutical Industries Ltd. -2.84%10.102.0%$149.73m
MYLMylan NV -1.31%21.853.2%$134.26m
BBIOBridgeBio Pharma, Inc. -0.76%34.130.0%$15.39m
VBIVVBI Vaccines, Inc. -0.78%1.280.2%$10.20m
TXMDTherapeuticsMD, Inc. -3.13%2.4822.2%$9.44m
RDYDr. Reddy's Laboratories Ltd. -0.87%41.982.0%$6.54m
ABEOAbeona Therapeutics, Inc. -6.74%2.634.5%$4.68m
TAROTaro Pharmaceutical Industries Ltd. -1.23%83.626.5%$3.62m
KINKindred Biosciences, Inc. -1.66%9.500.3%$1.82m
LFVNLifeVantage Corp. -1.17%15.253.4%$1.17m
JAGXJaguar Health, Inc. -5.16%0.762.3%$0.90m
CPHIChina Pharma Holdings, Inc. -3.81%0.360.1%$0.53m
COCPCocrystal Pharma, Inc. 0.00%0.730.0%$0.17m

Company Profile

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.